PharmiWeb.com - Global Pharma News & Resources
29-Aug-2023

Insulin Syringes Market Update 2023: Predicted to Surpass USD 2.40 Billion by 2030, Report

Insulin syringes market was valued at $1,561.20 million in 2020, and is projected to reach $2,401.51 million by 2030, registering a CAGR of 4.4% from 2021 to 2030. An insulin syringe aids in delivering insulin to diabetic patients in required doses. The insulin syringes consist of three parts-a needles, a barrel, and a plunger, and is available in various sizes. The needle is usually thin and short and covered with a special material such as silicone in order to allow it to slide through the skin causing minimal pain. Barrel is the chamber that holds the insulin. It is marked with calibrations designed to show the units of insulin being injected. The plunger is the narrow rod that slides up and down the length of the barrel. it serves to either draw the insulin into the barrel or release the insulin from the barrel through the needle. Further, the size of the insulin syringe is selected based on the desired dosage of insulin to be administered to diabetic patients.

๐‹๐ข๐ฌ๐ญ ๐จ๐Ÿ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ :

Novo Nordisk A/S, , Biocon Ltd Abbott Laboratories, Terumo Corporation, Cardinal Health Inc, Beckton and Dickinson Company, Eli Lilly and Company, Nipro Medical Corporation, Medline Industries and Hindustan syringe and medical device Ltd The other players in the value chain (not included in the report) are Medtronic., Sanofi S.A and Braun Melunsun

๐…๐จ๐ซ ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/3740

On the basis of syringe size, 3c/10 cc syringes(0.3ml) segment holds the largest share in market in 2020. The growth of the segment is attributable to the factors such as increase in use of 3/10cc syringes (0.3ml) due to rise in the prevalence of Type 1diabetes across the world are the key factor anticipating the growth of market.

On the basis of disease type, type 2 diabetes segment holds the largest share in market in 2020. The growth of the segment is attributable to the factors such as rise in the adoption of unhealthy lifestyles surge in prevalence of type diabetes across the world are the key factor anticipating the growth of market.

On the basis of end user, hospital & clinics segment holds the largest share in market in 2020 The growth of the segment is attributable to the factors such as rise in geriatric population and large patients pool and surge in prevalence type 2 diabetes across the world, which require the administration of insulin with the help of insulin syringes are the key factor anticipating the growth of market.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/3740

Region wise, North America acquired a major share of insulin syringes market in 2020 owing, high prevalence of diabetes, increase in healthcare expenditures and presence of key players of insulin syringe manufacturers. However, Asia-Pacific is expected to grow at the highest rate during the forecast period, owing to rise in diabetes prevalence in Asia- Pacific (coupled with large diabetic & pre-diabetic patient population), strengthening distribution networks of global product manufacturers in the region, &, continued expansion of advanced medical facilities in emerging countries (such as China & India) are the key factors anticipating the growth of market.

๐•๐€๐‹๐”๐„ ๐๐‘๐Ž๐๐Ž๐’๐ˆ๐“๐ˆ๐Ž๐๐’ ๐‘๐„๐‹๐€๐“๐„๐ƒ ๐“๐Ž ๐“๐‡๐„ ๐‘๐„๐๐Ž๐‘๐“:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report

Comprehensive quantitative and qualitative insights at segment and sub-segment level

Covid 19 impact trends and perspective

Granular insights at global/regional/country level

Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

Blanket coverage on competitive landscape

Winning imperatives

Exhaustive coverage on โ€˜Strategic Developmentsโ€™ registered by leading players of the market

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โ€œMarket Research Reportsโ€ and โ€œBusiness Intelligence Solutions.โ€ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Editor Details

  • Company:
    • The Wire Times
Last Updated: 29-Aug-2023